{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Boceprevir  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Boceprevir. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Boceprevir  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "boceprevir",
    "trial_2_text": "Boceprevir  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Boceprevir Supplement: 60 participants will take Boceprevir 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Boceprevir. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Boceprevir  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "78": 0.2629069983959198,
      "87": 0.2605017423629761,
      "9": 0.18061929941177368,
      "64": 0.1725757122039795,
      "17": 0.16829122602939606,
      "123": 0.15304769575595856,
      "21": 0.14873050153255463,
      "46": 0.14108659327030182,
      "189": 0.13723011314868927,
      "173": 0.1308000534772873,
      "228": 0.12619712948799133,
      "79": 0.12322026491165161,
      "68": 0.11419960856437683,
      "14": 0.11338219791650772,
      "37": 0.11254826933145523,
      "20": 0.10961033403873444,
      "67": 0.10913298279047012,
      "188": 0.10433012992143631,
      "243": 0.1027582660317421,
      "85": 0.09871119260787964,
      "104": 0.09609486162662506,
      "49": 0.09376262873411179,
      "114": 0.09357589483261108,
      "77": 0.09105376154184341,
      "350": 0.09043529629707336,
      "2": 0.09022514522075653,
      "126": 0.08743833005428314,
      "101": 0.08639706671237946,
      "177": 0.08137287199497223,
      "193": 0.07692243158817291,
      "29": 0.07599712163209915,
      "139": 0.07564502209424973,
      "72": 0.07238845527172089,
      "86": 0.07155616581439972,
      "191": 0.06999226659536362,
      "200": 0.066228486597538,
      "18": 0.06554730981588364,
      "130": 0.064283087849617,
      "136": 0.06308528780937195,
      "239": 0.060097452253103256,
      "131": 0.05938292667269707,
      "28": 0.05779382213950157,
      "61": 0.05513300374150276,
      "116": 0.0543709471821785,
      "211": 0.05398940294981003,
      "151": 0.05362970381975174,
      "441": 0.05173846334218979,
      "76": 0.051682647317647934,
      "82": 0.051427002996206284,
      "234": 0.05139162018895149,
      "69": 0.05117051303386688,
      "261": 0.05073462426662445,
      "36": 0.04967332258820534,
      "257": 0.04921950027346611,
      "179": 0.047556210309267044,
      "147": 0.0473938062787056,
      "27": 0.04721340909600258,
      "396": 0.04710174351930618,
      "30": 0.04633597284555435,
      "269": 0.045833077281713486,
      "356": 0.04582304507493973,
      "355": 0.04580679535865784,
      "180": 0.04553615674376488,
      "122": 0.04434587433934212,
      "38": 0.04431668296456337,
      "194": 0.044064391404390335,
      "186": 0.04387952387332916,
      "249": 0.0429859384894371,
      "339": 0.042406778782606125,
      "5": 0.04192272946238518,
      "212": 0.04181757569313049,
      "138": 0.04121901094913483,
      "102": 0.04079669713973999,
      "154": 0.03960883617401123,
      "35": 0.039489202201366425,
      "166": 0.0393957681953907,
      "288": 0.03931189328432083,
      "204": 0.03913626819849014,
      "121": 0.03774401918053627,
      "454": 0.03771615028381348,
      "345": 0.03743699565529823,
      "276": 0.037351347506046295,
      "92": 0.03713278844952583,
      "371": 0.037067998200654984,
      "11": 0.03689296543598175,
      "382": 0.036085858941078186,
      "96": 0.03569445386528969,
      "297": 0.034804604947566986,
      "4": 0.03417579457163811,
      "456": 0.033800359815359116,
      "221": 0.03354049474000931,
      "253": 0.033383261412382126,
      "535": 0.03256352245807648,
      "282": 0.03244085982441902,
      "164": 0.031774066388607025,
      "98": 0.03144468739628792,
      "75": 0.0313827209174633,
      "132": 0.03095225617289543,
      "422": 0.030276397243142128,
      "363": 0.030070671811699867
    },
    "trial_2_ae": {
      "78": 0.2629069983959198,
      "87": 0.2605017423629761,
      "9": 0.18061929941177368,
      "64": 0.1725757122039795,
      "17": 0.16829122602939606,
      "123": 0.15304769575595856,
      "21": 0.14873050153255463,
      "46": 0.14108659327030182,
      "189": 0.13723011314868927,
      "173": 0.1308000534772873,
      "228": 0.12619712948799133,
      "79": 0.12322026491165161,
      "68": 0.11419960856437683,
      "14": 0.11338219791650772,
      "37": 0.11254826933145523,
      "20": 0.10961033403873444,
      "67": 0.10913298279047012,
      "188": 0.10433012992143631,
      "243": 0.1027582660317421,
      "85": 0.09871119260787964,
      "104": 0.09609486162662506,
      "49": 0.09376262873411179,
      "114": 0.09357589483261108,
      "77": 0.09105376154184341,
      "350": 0.09043529629707336,
      "2": 0.09022514522075653,
      "126": 0.08743833005428314,
      "101": 0.08639706671237946,
      "177": 0.08137287199497223,
      "193": 0.07692243158817291,
      "29": 0.07599712163209915,
      "139": 0.07564502209424973,
      "72": 0.07238845527172089,
      "86": 0.07155616581439972,
      "191": 0.06999226659536362,
      "200": 0.066228486597538,
      "18": 0.06554730981588364,
      "130": 0.064283087849617,
      "136": 0.06308528780937195,
      "239": 0.060097452253103256,
      "131": 0.05938292667269707,
      "28": 0.05779382213950157,
      "61": 0.05513300374150276,
      "116": 0.0543709471821785,
      "211": 0.05398940294981003,
      "151": 0.05362970381975174,
      "441": 0.05173846334218979,
      "76": 0.051682647317647934,
      "82": 0.051427002996206284,
      "234": 0.05139162018895149,
      "69": 0.05117051303386688,
      "261": 0.05073462426662445,
      "36": 0.04967332258820534,
      "257": 0.04921950027346611,
      "179": 0.047556210309267044,
      "147": 0.0473938062787056,
      "27": 0.04721340909600258,
      "396": 0.04710174351930618,
      "30": 0.04633597284555435,
      "269": 0.045833077281713486,
      "356": 0.04582304507493973,
      "355": 0.04580679535865784,
      "180": 0.04553615674376488,
      "122": 0.04434587433934212,
      "38": 0.04431668296456337,
      "194": 0.044064391404390335,
      "186": 0.04387952387332916,
      "249": 0.0429859384894371,
      "339": 0.042406778782606125,
      "5": 0.04192272946238518,
      "212": 0.04181757569313049,
      "138": 0.04121901094913483,
      "102": 0.04079669713973999,
      "154": 0.03960883617401123,
      "35": 0.039489202201366425,
      "166": 0.0393957681953907,
      "288": 0.03931189328432083,
      "204": 0.03913626819849014,
      "121": 0.03774401918053627,
      "454": 0.03771615028381348,
      "345": 0.03743699565529823,
      "276": 0.037351347506046295,
      "92": 0.03713278844952583,
      "371": 0.037067998200654984,
      "11": 0.03689296543598175,
      "382": 0.036085858941078186,
      "96": 0.03569445386528969,
      "297": 0.034804604947566986,
      "4": 0.03417579457163811,
      "456": 0.033800359815359116,
      "221": 0.03354049474000931,
      "253": 0.033383261412382126,
      "535": 0.03256352245807648,
      "282": 0.03244085982441902,
      "164": 0.031774066388607025,
      "98": 0.03144468739628792,
      "75": 0.0313827209174633,
      "132": 0.03095225617289543,
      "422": 0.030276397243142128,
      "363": 0.030070671811699867
    }
  },
  "safety": {
    "trial_1_safety": 0.3600308895111084,
    "trial_2_safety": 0.3600308895111084
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.47818541526794434
  }
}